Tuberous Sclerosis Complex (TSC) is a genetic disorder characterized by the growth of numerous non-cancerous (benign) tumors in many parts of the body. These tumors can occur in the skin, brain, kidneys, and other organs, in some cases leading to significant health problems. It was firstly described in the 1880s by French neurologist Désiré-Magloire Bourneville.
Tuberous Sclerosis Complex Market Analysis
The Tuberous Sclerosis Complex market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Tuberous Sclerosis Complex market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The market segment gives a thorough detail of Tuberous Sclerosis Complex market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Tuberous Sclerosis Complex Epidemiology
The Tuberous Sclerosis Complex epidemiology division provides insights about historical and current Tuberous Sclerosis Complex patient pool and forecasted trends for every seven major countries.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.
The Tuberous Sclerosis Complex Epidemiologypart of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Tuberous Sclerosis Complex Marketed & Emerging Drugs
Drug chapter segment of the Tuberous Sclerosis Complex report encloses the detailed analysis of Tuberous Sclerosis Complex marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
It also helps to understand the Tuberous Sclerosis Complex clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
Some of the key companies in Tuberous Sclerosis Complex Market include:
-
Novartis Pharmaceuticals
-
Nobelpharma Co., Ltd
-
GW Pharmaceuticals
-
Takeda Pharmaceutical Company Limited
Increasing awareness, the introduction of novel drugs and changing lifestyle are some of the key factors driving the growth of the Tuberous Sclerosis Complex market globally.
Owing to the launch of upcoming therapies, the Tuberous Sclerosis Complex market size is expected to increase during forecast period (2019-2030)
About Delveinsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.